Español(Spanish Formal International)Português (pt-PT)Russian (CIS)Polish (Poland)English (United Kingdom)
logo-frase

ISO_9001IPAC1_70

Недоступен ни однин перевод.

Orfeu Flores

Dr. Orfeu Flores is STAB VIDAs CEO, and one of STAB VIDAs founder. Orfeu is currently President of GROUP STAB and CEO of STAB SGPS. Since the emmergence of GROUP STAB, in 1995, Dr. Orfeu has helped trnaform this biotechnology venture into an exemple of sucess in Portugal. Dr. Orfeu graduated in Applied Chemistry at Universidade Nova de Lisboa and he is currently finishing his PhD in Molecular and genetic Engineering. Orfeu did his PhD work at Instituto Gulbenkian Ciência (IGC) and at Instituto de Técnologia Química e Biológica (ITQB), both in Oeiras, Portugal. In 1998, Dr. Orfeu attended the Masters Program in "technology and Commercialization", promoted by Instituto Superior Técnico,Universidade Técnica de Lisboa (IST/UTL), and IC2/U. Texas, USA. Dr, Orfeu presently belongs to the boards of IBET, AIESEC and PNCR, and collaborates with the European Commission, in the area of Molecular Biology and SME innovation.

 

Daniela Leão

Dr. Daniela Leão is the Chief Intellectual Poperty Officer (CIPO) and Chief Operations Officer (COO) for STAB VIDA. Daniela graduated in Applied Chemistry for at Universidade Nova de Lisboa, and was an investigator at the Genetics Department of Instituto de Medicina Tropical, in Lisbon, between 1996 and 1998. Since then, she has been busy assuming different positions in companies of GRUPOSTAB, and was nominated as the Biotechnology Unit Director, being now the Head of DNA Lab. During the past few years, Dr. Daniela Leão has accumulated a vast experience is subjects such as copyright, brands and patents, as well as innovation and technology transfer.

 

Sofia Goes

Dr. Sofia Goes is the STAB VIDA former CEO, actual CSO. Sofia has graduated in Biology form Faculdade de Ciências de Lisboa in 1991. Sofia has obtained a PhD degree in Molecular Biology and genetic Engineering at Ludwig - Maximilians Universitat, Munich, Germany (1999). Between 1995 and 2000 Sofia worked a Instituto de Biologia Experimental e Tecnológica (IBET) as manager of Scientific Marketing and Associate Director, where she accumulated a great experinece in marketing, fund raising and query project coordination applied to industry. Sofia managed STAB VIDA since April 2000 to ......

Papers from our Shareholders

Mechanisms of induction of chromosomal aberrations by hydroquinone in V79 cells

Mechanisms_of_induction_of_chromosomal_aberrations_by_hydroquinone_in_V79_cellsBy Maria do Céu Silva, Jorge Gaspar1, Isabel Duarte Silva1, Daniela Leão and José Rueff

Hydroquinone occurs naturally in bacteria and plants and it is also manufactured for commercial use. Human exposure to this compound can occur by environmental, occupational, dietary and cigarette smoke exposure and from exposure to benzene, which can be metabolized to this compound. However, the main source of exposure to this compound is dietary, since hydroquinone is a naturally occurring compound in many foods. Hydroquinone can be metabolized to benzoquinones, which are potent haematotoxic, genotoxic and carcinogenic compounds that can also induce the formation of radical species, predisposing cells to oxidative damage. In order to clarify the involvement of radical species in the genotoxicity of hydroquinone, the induction of chromosomal aberrations in V79 cells was studied along with the assessment of the production of hydroxyl radicals at different pH values (6.0, 7.4 and 8.0), as well as the effect of antioxidant enzymes [catalase and superoxide dismutase (SOD)] on the clastogenic effect of hydroquinone. The results obtained indicate that the clastogenic activity of hydroquinone is dependent on the pH, suggesting that deprotonation is a fundamental step leading to DNA lesions under the experimental conditions used. The addition of S9 mix, SOD or SOD and catalase signi®cantly decreased the clastogenic activity, suggesting the involvement of superoxide anion and hydrogen peroxide in the genotoxicity of hydroquinone. However, other species generated in the auto-oxidation process of hydroquinone, such as the semiquinone radical or the quinone, also seem to play a role in its genotoxicity, since the addition of antioxidant enzymes (catalase and SOD) or S9 mix do not lead to a complete abolition of the observed genotoxic activity. These results suggest the existence of at least two mechanisms associated with the genotoxic activity of this compound.

Retrospective analysis of clinical yeast isolates in a hospital in the centre of Portugal: spectrum and revision of the identification procedures

Retrospective_analysis_of_clinical_yeast_isolates_in_a_hospital_in_the_centre_of_Portugal

By Cristiana Paulo; Cristina Mourão; Pedro M. Veiga; Joana M. Marques; Graça Rocha; Ana F. Alves; Amparo Querol; António A. Meliço-Silvestre; Isabel Gonçalves; Orfeu Flores; Carla Clemente; Teresa Gonçalves

We conducted a four-year (2003-2006) retrospective study of yeasts recovered in a hospital laboratory in the centre of Portugal to evaluate the epidemiology of yeast infections. Clinical isolates and data were gathered from 751 patients corresponding to 906 episodes of yeast infection. The isolates were first identified using classical and commercial methods, routinely employed at the hospital laboratory.
We then re-identified the same isolates using RFLP of the ITS 5.8S rRNA gene and sequence of the D1/D2 domain of the 26S rRNA gene. Candida parapsilosis isolates were re-identified using the Ban I digestion of the SADH gene. C. albicans was the most frequently isolated of the yeasts found in the analysed specimens, with an overall incidence of 69.6% and then in deceasing order, C. glabrata, C. tropicalis, C. parapsilosis and C. krusei. C. parapsilosis was most frequently recovered from younger patients, decreasing with age, while C. glabrata occurrence increased with age. We found an increased number of cases of fungemia per 100,000 people per year, reaching a maximum of 4.4 during 2006.

Keywords Yeast infections, molecular yeast identification, risk factor, Candida metapsilosis, Candida orthopsilosis

Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification

_Differentiation_of_Cryptococcus_neoformans_varieties_and_Cryptococcus_gattii_using_CAP59-based_loop-mediated_isothermal_DNA_amplification


By S. Lucas, M. da Luz Martins, Orfeu Flores, W. Meyer, I. Spencer-Martins and J. Inácio

Abstract

Members of the Cryptococcus species complex (C. neoformans and C. gattii) are opportunistic pathogens responsible for frequently fatal cases of meningoencephalitis. These yeasts have been classified into five serotypes. Serotypes A andDare assigned to C. neoformans var. grubii and C. neoformans var. neoformans, respectively, Serotype AD strains are hybrids and serotype B and C strains are considered to belong to the related but distinct species C. gattii. Previous studies have identified ‘serotype-associated’ alleles of several genes in the Cryptococcus species complex. We developed a loop-mediated isothermal DNA amplification method using CAP59 allele- specific primers to identify the serotypes A, D and B/C of the Cryptococcus species complex.


Keywords: Cryptococcus gattii, Cryptococcus neoformans, loopmediated isothermal DNA amplification